Page last updated: 2024-08-21

arsenic trioxide and Fibrosarcoma

arsenic trioxide has been researched along with Fibrosarcoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YA; Chiu, HW; Ho, SY; Lin, JH; Wang, YJ1
An, S; Chung, HY; Han, CJ; Hong, SI; Jin, HO; Kwak, HJ; Lee, HC; Lee, JY; Lee, SH; Park, CM; Park, IC; Park, MJ; Rhee, CH; Woo, SH1
Brown, SL; Griffin, RJ; Kim, JH; Lew, YS; Song, CW1

Other Studies

3 other study(ies) available for arsenic trioxide and Fibrosarcoma

ArticleYear
Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis.
    Autophagy, 2010, Volume: 6, Issue:3

    Topics: Adult; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Neoplasm Transplantation; Oxides

2010
Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
    Journal of cellular biochemistry, 2005, Aug-01, Volume: 95, Issue:5

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Northern; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Electrophoretic Mobility Shift Assay; Fibrosarcoma; Humans; JNK Mitogen-Activated Protein Kinases; Luciferases; Matrix Metalloproteinase 2; Neoplasm Invasiveness; NF-kappa B; Oxides; p38 Mitogen-Activated Protein Kinases; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; Tissue Inhibitor of Metalloproteinases; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator

2005
Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown.
    Cancer research, 1999, Dec-15, Volume: 59, Issue:24

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biological Transport; Disease Models, Animal; Fibrosarcoma; Male; Metabolic Clearance Rate; Methylcholanthrene; Mice; Mice, Inbred BALB C; Necrosis; Oxides; Perfusion

1999